Lyons, France

Jorge Ronco


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 42(Granted Patents)


Location History:

  • La Mulatière, FR (2002)
  • Lyons, FR (2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):

Title: Innovations by Jorge Ronco: Advancements in Vaccine Composition

Introduction

Jorge Ronco is a prominent inventor based in Lyons, France, known for his significant contributions in the field of vaccine development. With a total of two patents to his name, he focuses on enhancing vaccine efficacy through innovative adjuvant compositions.

Latest Patents

His latest patents include groundbreaking inventions aimed at improving vaccine formulations. One of his notable patents is for an adjuvant for a vaccine composition. This invention features an amphipathic compound that comprises a sterol-derived lipophilic grouping, bound to a cationic grouping, intended for use as an adjuvant in vaccine delivery. Specifically, it discusses the lipophilic grouping being a cholesterol derivative while the cationic grouping includes either a quaternary ammonium or protonatable amine.

Additionally, Ronco's second patent outlines the method of inducing an immune response to a subunit antigen in a non-responding subject. This method includes administering a composition comprising the subunit antigen alongside an amphipathic compound, with a hepatitis B antigen identified as a preferred target and DC-chol as the amphipathic compound of choice.

Career Highlights

Jorge Ronco serves as an inventor at Aventis Pasteur S.A., a leading company in vaccine production. His work drives innovation in the development of vaccine technologies that potentially enhance immune responses and therapeutic outcomes.

Collaborations

In his professional journey, Ronco collaborates with renowned colleagues such as Jean Haensler and Emmanuelle Trannoy. These collaborative efforts foster a dynamic environment for research and development, driving forward the fields of immunology and vaccine technology.

Conclusion

Jorge Ronco's contributions through his patents not only highlight his inventive spirit but also underscore the vital role that innovation plays in the advancement of healthcare and vaccine efficacy. As he continues to work at Aventis Pasteur S.A., his inventions will likely have a lasting impact on the future of immunization strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…